Allergic Bronchopulmonary Aspergillosis: The Term Fails Us
Lung Diseases other than Asthma
Monday, March 5, 2018: 7:00 AM-8:00 AM
Hyatt, Convention Level, Celebration 1
1.00 CME/CE
Primary Discussion Leaders:
Alan P. Knutsen, MD FAAAAI
Andrew J. Wardlaw, MD PhD

Learning Objectives:
  1. Discuss the clinical entity described by allergic bronchopulmonary aspergillosis and appreciate its limitations
  2. Describe the clinical implications of recognizing a subtype of patients described by severe asthma with fungal sensitization
  • ABAI-AAAAI.pdf (100.1 kB)
  • See more of: Session